Sharp uptake in use of new weight loss and glucose-lowering medications
Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.
from Latest Science News -- ScienceDaily https://ift.tt/UkLung7
from Latest Science News -- ScienceDaily https://ift.tt/UkLung7
Comments
Post a Comment